trending Market Intelligence /marketintelligence/en/news-insights/trending/6la4yaZPU641wsaTLjUU-g2 content esgSubNav
In This List

Esperion Therapeutics executive chairman retires, takes adviser role

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Esperion Therapeutics executive chairman retires, takes adviser role

Esperion Therapeutics Inc. said Roger Newton retired from his executive chairman and chief scientific officer positions on Dec. 8.

Newton will transition to a scientific adviser role and remain a member of the company's board.